Company: RGNX
Filing Date: 2025-03-13
Form Type: POS AM
Source: 0001193125-25-053998
Chunk: 38

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: POS AM
Chunk 38
---
 this prospectus by reference to the Annual Report on Form 10-K for the year ended
December 31, 2024 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

27

Common Stock

Preferred Stock

Warrants

Debt Securities

Rights

Units

PROSPECTUS

, 2025

PART II INFORMATION NOT REQUIRED IN PROSPECTUS

| Item 14. | Other Expenses of Issuance and Distribution |

The following table sets forth an itemization of all estimated expenses in connection with the issuance and distribution of the securities being registered, all of which will be borne by the registrant.

| SEC registration fee                                                  |     | $ | 45,930 |
| Legal fees and expenses                                               |     |   |      * |
| Accounting fees and expenses                                          |     |   |      * |
| Transfer agent and registrar fees and expenses                        |     |   |      * |
| Stock exchange listing fees                                           |     |   |      * |
| Trustee fees and expenses                                             |     |   |      * |
| Printing, FINRA filing fee (if applicable) and miscellaneous expenses |     |   |      * |
| Total                                                                 |     | $ |      * |

| * | These fees and expenses are calculated based on the amount of securities offered and number of offerings                                                                                                                           
 accordingly cannot be estimated at this time. The estimate of such expenses in connection with securities to be offered and sold pursuant to this registration statement will be included in the applicable prospectus supplement. |

| Item 15. | Indemnification of Directors and Officers |

Section 102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of its directors to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Section 145 of the Delaware General Corporation Law authorizes a court to award, or a corporation’s board of directors to grant, indemnity to directors and officers under certain circumstances and subject to certain limitations. The terms of Section 145 of the Delaware General Corporation Law are sufficiently broad to permit indemnification